{"id":5030,"date":"2018-09-14T18:56:13","date_gmt":"2018-09-14T22:56:13","guid":{"rendered":"http:\/\/www.ipoboutique.com\/blog\/?p=5030"},"modified":"2018-09-14T18:56:22","modified_gmt":"2018-09-14T22:56:22","slug":"new-filings-updated-terms-9-14-18","status":"publish","type":"post","link":"https:\/\/www.ipoboutique.com\/blog\/new-filings-updated-terms-9-14-18\/","title":{"rendered":"New Filings & Updated Terms (9.14.18)"},"content":{"rendered":"

This is the latest look at the IPO Pipeline including the newest filings that have registered with the SEC in the last seven days.<\/p>\n

<\/p>\n

IPO Boutique keeps apprised of the active pipeline. Currently there are 79active IPOs in the pipeline as of September 14, 2018. No SPACs or Unit Offerings are included. While the numbers may look diminished, we outlined why \u201clooks may be perceiving\u201d when it comes to the IPO pipeline\u00a0in this article.<\/strong><\/a><\/p>\n

\"\"<\/a><\/p>\n

NEW FILINGS<\/strong><\/p>\n

Company: Studio City International Holdings Limited
\nSymbol: MSC
\nDescription: Studio City is a world-class gaming, retail and entertainment resort located in Cotai, Macau.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriter(s): Deutsche Bank, Credit Suisse, Morgan Stanley
\nFiled: 9-7-18
\nListed Cash Raise: $115m<\/p>\n

Company: Kodiak Sciences Inc.
\nSymbol: KOD
\nDescription: They are a clinical stage biopharmaceutical company specializing in novel therapeutics to treat chronic, high-prevalence retinal diseases.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriter(s): Morgan Stanley, BofA Merrill Lynch
\nCo-Manager(s): Barclays, Chardan
\nFiled: 9-7-18
\nListed Cash Raise: $100m<\/p>\n

Company: Allogene Therapeutics, Inc.
\nSymbol: ALLO
\nDescription: They are a clinical stage immuno-oncology company pioneering the development and commercialization of genetically engineered allogeneic T cell therapies for the treatment of cancer.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriter(s): Goldman Sachs & Co, J.P. Morgan, Cowen, Jefferies
\nFiled: 9-14-18
\nListed Cash Raise: $100m<\/p>\n

Company: Osmotica Pharmaceuticals plc
\nSymbol: OSMT
\nDescription: They are a fully integrated biopharmaceutical company focused on the development and commercialization of specialty products that target markets with underserved patient populations.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriter(s): Jefferies, Barclays, RBC
\nFiled: 9-14-18
\nListed Cash Raise: $100m<\/p>\n

Company: Anaplan, Inc.
\nSymbol: PLAN
\nDescription: Anaplan is pioneering the category of Connected Planning, which allows organizations to transform their businesses by making better and faster decisions.
\nTrade Date: TBD
\nShares: TBD
\nPrice Range: TBD
\nUnderwriter(s): Goldman Sachs, Morgan Stanley, Barclays
\nCo-Manager(s): KeyBanc Capital, Canaccord Genuity, Evercore ISI, JMP Securities, Needham & Co., Piper Jaffray, SunTrust Robinson Humphrey
\nFiled: 9-14-18
\nListed Cash Raise: $100m<\/p>\n

TERMS ADDED:<\/strong><\/p>\n

Company: Y-mAbs Therapeutics, Inc.
\nSymbol: YMAB
\nDescription: They are a late-stage clinical biopharmaceutical company focused on the development and commercialization of novel, antibody-based therapeutic products for the treatment of cancer.
\nNew York.
\nTrade Date: 9\/21
\nShares: 5.3 million
\nPrice Range: $14.00-$16.00
\nUnderwriter(s): BofA Merrill Lynch, Cowen, Canaccord Genuity
\nCo-Manager(s): BTIG
\nTerms Added: 9-7-18<\/p>\n

Company: Remora Royalties
\nSymbol: RRI
\nDescription: They are a growth-oriented Delaware corporation formed to own and acquire overriding royalty, mineral and royalty interests in oil and natural gas properties.
\nNew York.
\nTrade Date: 9\/21
\nShares: 5.3 million
\nPrice Range: $19.00-$21.00
\nUnderwriters: RBC Capital, Wells Fargo, UBS Investment Bank, Stifel
\nCo-Manager(s); Stephens Inc., Seaport Global Securities
\nTerms Added: 9-10-18<\/p>\n

Company: Bank7 Corp.
\nSymbol: BSVN
\nDescription: They are Bank7 Corp., a bank holding company headquartered in Oklahoma City, Oklahoma.
\nNew York.
\nTrade Date: 9\/20
\nShares: 3.325 million
\nPrice Range: $18.00-$21.00
\nUnderwriters: Keefe Bruyette & Woods, Stephens Inc.
\nCo-Manager: Sandler O’ Neill
\nTerms Added: 9-10-18<\/p>\n

Company: Viomi Technology Co., Ltd.
\nSymbol: VIOT
\nDescription: They have developed a unique IoT @ Home platform, consisting of an ecosystem of innovative IoT-enabled smart home products, or IoT products, together with a suite of complementary consumable products and value-added businesses.
\nTrade Date: 9\/25
\nShares: 11.4 million ADSs
\nPrice Range: $9.00-$11.00
\nUnderwriters: Morgan Stanley, CICC
\nCo-Manager(s): Needham & Co.
\nTerms Added: 9-11-18<\/p>\n

Company: X Financial
\nSymbol: XYF
\nDescription: They are a leading technology-driven personal finance company in China focused on serving China’s underserved prime borrowers and mass affluent investor.
\nNew York.
\nTrade Date: 9\/25
\nShares: 11 million
\nPrice Range: $9.00-$11.00
\nUnderwriters :Deutsche Bank, Morgan Stanley
\nCo-Manager(s): EBS International,China Merchant Securities, AMTD Tiger
\nTerms Added: 9-12-18<\/p>\n

Company: Arco Platform Limited
\nSymbol: ARCE
\nDescription: They provide a complete pedagogical system with technology-enabled features to deliver educational content to private schools in Brazil.
\nNew York.
\nTrade Date: 9\/26
\nShares: 11.1 million
\nPrice Range: $15.50-$17.50
\nUnderwriters: Goldman Sachs, Morgan Stanley, Itau BBA, BofA Merrill Lynch, Allen & Co., BTG Pactual, UBS
\nTerms Added: 9-12-18<\/p>\n

Company: SVMK, Inc. (SurveyMonkey)
\nSymbol: SVMK
\nDescription: They are a leading global provider of survey software products that enable organizations to engage with their key constituents, including their customers, employees and the markets they serve.
\nTrade Date: 9\/26
\nShares: 13.5 million
\nPrice Range: $9.00-$11.00
\nUnderwriters: J.P. Morgan, Allen & Company, BofA Merrill Lynch, Credit Suisse, UBS Investment Bank, Wells Fargo Securities
\nCo-Manager(s): SunTrust Robinson Humphrey, CODE Advisors, Foros, JMP Securities, LionTree
\nTerms Added: 9-13-18<\/p>\n

Company: Arvinas, Inc
\nSymbol: ARVN
\nDescription: They are a biopharmaceutical company dedicated to improving the lives of patients suffering from debilitating and life-threatening diseases through the discovery, development and commercialization of therapies to degrade disease-causing proteins.
\nTrade Date: 9\/27
\nShares: 6.67 million
\nPrice Range: $14.00-$16.00
\nUnderwriters: Goldman Sachs, Citigroup, Piper Jaffray
\nTerms Added: 9-14-18<\/p>\n

Company: LAIX Inc.
\nSymbol: LAIX
\nDescription: They are a leading artificial intelligence (AI) company in China that creates and delivers products and services to popularize English learning.
\nNew York.
\nTrade Date: 9\/27
\nShares: 5.75 million ADSs
\nPrice Range: $11.50-$13.50
\nUnderwriter(s): Morgan Stanley, Goldman Sachs (Asia)
\nTerms Added: 9-14-18<\/p>\n","protected":false},"excerpt":{"rendered":"

This is the latest look at the IPO Pipeline including the newest filings that have registered with the SEC in the last seven days.<\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"zakra_general_container_width":0,"zakra_general_content_width":0,"zakra_general_sidebar_width":0,"zakra_sticky_header":"customizer","zakra_header_main_area":true,"zakra_site_logo_width":0,"zakra_header_top_enabled":"customizer","zakra_header_top_style":"customizer","zakra_primary_menu_item_style":"customizer","zakra_page_header_text_color":"","zakra_page_header_layout":"customizer","zakra_page_title_bg":"","zakra_footer_widgets_bg_image":0,"zakra_page_title_bg_repeat":"customizer","zakra_page_title_bg_position":"customizer","zakra_page_title_bg_size":"customizer","zakra_page_title_bg_attachment":"customizer","zakra_breadcrumbs_enabled":"customizer","zakra_breadcrumbs_text_color":"","zakra_breadcrumbs_separator_color":"","zakra_breadcrumbs_link_color":"","zakra_breadcrumbs_link_hover_color":"","zakra_page_title_bg_image":0,"zakra_footer_widgets_enabled":"customizer","zakra_footer_column_layout_1_style":"customizer","zakra_footer_widgets_bg":"","zakra_footer_widgets_bg_repeat":"customizer","zakra_footer_widgets_bg_position":"customizer","zakra_footer_widgets_bg_size":"customizer","zakra_footer_widgets_bg_attachment":"customizer","zakra_footer_bar_enabled":"customizer","zakra_footer_bar_style":"customizer","footnotes":""},"categories":[1536],"tags":[],"class_list":["post-5030","post","type-post","status-publish","format-standard","hentry","category-subscriber-content"],"_links":{"self":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/5030","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/comments?post=5030"}],"version-history":[{"count":3,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/5030\/revisions"}],"predecessor-version":[{"id":5048,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/posts\/5030\/revisions\/5048"}],"wp:attachment":[{"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/media?parent=5030"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/categories?post=5030"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.ipoboutique.com\/blog\/wp-json\/wp\/v2\/tags?post=5030"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}